BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 2785904)

  • 1. Induction potency of various beta-lactam derivatives in gram-negative rods.
    Cullmann W; Dick W
    Chemotherapy; 1989; 35(1):43-53. PubMed ID: 2785904
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effects on beta-lactam susceptibility of phenotypic induction and genotypic derepression of beta-lactamase synthesis.
    Shannon K; Phillips I
    J Antimicrob Chemother; 1986 Dec; 18 Suppl E():15-22. PubMed ID: 3102451
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Induction of beta-lactamases in Enterobacter cloacae with beta-lactam antibiotics].
    Cullmann W; Dick W
    Immun Infekt; 1984 Feb; 12(1):29-34. PubMed ID: 6335880
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro expression of beta-lactam-induced response by clinical gram-negative bacteria with the potential for inducible beta-lactamase production.
    Bongaerts G; Roelofs-Willemse H
    Scand J Infect Dis; 1998; 30(6):579-83. PubMed ID: 10225386
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inducible type I beta-lactamases of gram-negative bacteria and resistance to beta-lactam antibiotics.
    Curtis NA; Eisenstadt RL; Rudd C; White AJ
    J Antimicrob Chemother; 1986 Jan; 17(1):51-61. PubMed ID: 3485092
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effects of clavulanic acid and sulbactam on beta-lactamase biosynthesis.
    Farmer TH; Reading C
    J Antimicrob Chemother; 1988 Aug; 22(2):105-11. PubMed ID: 3263350
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influence of temperature on beta-lactamase production and outer membrane proteins in gram-negative rods.
    Cullmann W; Dick W
    Chemotherapy; 1990; 36(4):277-86. PubMed ID: 2253497
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro activity of avibactam (NXL104) in combination with β-lactams against Gram-negative bacteria, including OXA-48 β-lactamase-producing Klebsiella pneumoniae.
    Aktaş Z; Kayacan C; Oncul O
    Int J Antimicrob Agents; 2012 Jan; 39(1):86-9. PubMed ID: 22041508
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Incidence of inducible beta-lactamases in gram-negative septicemia isolates from twenty-nine European laboratories. European Study Group on Antibiotic Resistance.
    Eur J Clin Microbiol; 1987 Aug; 6(4):460-6. PubMed ID: 3117535
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inducible beta-lactamases are principally responsible for the naturally occurring resistance towards beta-lactam antibiotics in Proteus vulgaris.
    Aspiotis A; Cullmann W; Dick W; Stieglitz M
    Chemotherapy; 1986; 32(3):236-46. PubMed ID: 3519112
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Accuracy of microdilution and the AutoMicrobic System in detection of beta-lactam resistance in gram-negative bacterial mutants with derepressed beta-lactamase.
    Washington JA; Knapp CC; Sanders CC
    Rev Infect Dis; 1988; 10(4):824-9. PubMed ID: 3263689
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Susceptibility of clinical isolates to expanded-spectrum beta-lactams alone and in the presence of beta-lactamase inhibitors.
    Qadri SM; Ueno Y; Cunha BA
    Chemotherapy; 1996; 42(5):334-42. PubMed ID: 8874972
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chromosomal beta-lactamase expression and resistance to beta-lactam antibiotics in Proteus vulgaris and Morganella morganii.
    Yang YJ; Livermore DM
    Antimicrob Agents Chemother; 1988 Sep; 32(9):1385-91. PubMed ID: 3058021
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical significance of beta-lactamase induction and stable derepression in gram-negative rods.
    Livermore DM
    Eur J Clin Microbiol; 1987 Aug; 6(4):439-45. PubMed ID: 3311738
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Importance of beta-lactamase induction.
    Phillips I; Shannon K
    Eur J Clin Microbiol Infect Dis; 1993; 12 Suppl 1():S19-26. PubMed ID: 8477758
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Selection and properties of Pseudomonas aeruginosa variants resistant to beta-lactam antibiotics.
    Cullman W; Büscher KH; Dick W
    Eur J Clin Microbiol; 1987 Aug; 6(4):467-73. PubMed ID: 3117536
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cefoxitin, N-formimidoyl thienamycin, clavulanic acid, and penicillanic acid sulfone as suicide inhibitors for different types of beta-lactamases produced by gram-negative bacteria.
    Sawai T; Tsukamoto K
    J Antibiot (Tokyo); 1982 Nov; 35(11):1594-602. PubMed ID: 6298169
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Type I beta-lactamases of gram-negative bacteria: interactions with beta-lactam antibiotics.
    Sanders CC; Sanders WE
    J Infect Dis; 1986 Nov; 154(5):792-800. PubMed ID: 3490520
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quantitative relationship between sensitivity to beta-lactam antibiotics and beta-lactamase production in gram-negative bacteria--I. Steady-state treatment.
    Frère JM
    Biochem Pharmacol; 1989 May; 38(9):1415-26. PubMed ID: 2785796
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lipopolysaccharide alterations responsible for combined quinolone and beta-lactam resistance in Pseudomonas aeruginosa.
    Leying HJ; Büscher KH; Cullmann W; Then RL
    Chemotherapy; 1992; 38(2):82-91. PubMed ID: 1591950
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.